Live Breaking News & Updates on Knee Endovascular Revascularization

Stay updated with breaking news from Knee endovascular revascularization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ABBOTT'S BREAKTHROUGH DISSOLVING STENT RECEIVES FDA APPROVAL FOR ARTERIES BELOW THE KNEE

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is . ....

San Francisco , United States , Alicia Swanson , Sahila Parikh , Endovascular Revascularization , Mike Comilla , Julie Tyler , Columbia University Irving Medical Center , Drug Administration , Eluting Resorbable Scaffold , Eluting Resorbable Scaffold System , Transcatheter Cardiovascular Therapeutics , New England Journal , Vasc Surg , Knee Endovascular Revascularization , Abbott Media , Abbott Financial ,